Self-care provision of contraception: Evidence and insights from contraceptive injectable self-administration.
As new reproductive health products become available, women increasingly want to take a participatory role in their health. New developments and formulations of contraceptive products provide an opportunity to support this evolving trend toward self-care. Self-care, as defined by the World Health Organization (WHO), highlights the ability of individuals to promote health, prevent disease, and manage their own health with or without the support of a health care provider. The recently released WHO Guidelines on Self-Care Interventions for Health: Sexual and Reproductive Health and Rights included new self-care recommendations related to use of family planning, including self-injection of injectable contraceptives and over-the-counter provision of oral contraceptive pills. This paper focuses on the research evidence of self-administration (self-injection) of subcutaneous depot medroxyprogesterone acetate (DMPA-SC), and the practical experience of providers, women, and family planning programs adopting self-injection practices. We also explore the role of self-care in the provision of other contraceptives.
['Brady|Martha|M|', 'Drake|Jennifer Kidwell|JK|', 'Namagembe|Allen|A|', 'Cover|Jane|J|']
D003267:Contraception D003271:Contraceptive Agents, Female D003273:Contraceptive Devices D005260:Female D006801:Humans D007279:Injections, Subcutaneous D017258:Medroxyprogesterone Acetate D012646:Self Administration D012651:Self Medication
Self-administration Self-injection DMPA-SC Locus of control Subcutaneous DMPA Women's autonomy